1. Metabolic Enzyme/Protease Vitamin D Related/Nuclear Receptor
  2. ROR
  3. Gala-SR

Gala-SR (Gala-SR1078) is an RORα agonist. Gala-SR ameliorates rhythm disorders by enhancing the amplitude of the circadian rhythm. Gala-SR can be used for the study of periodontitis.

For research use only. We do not sell to patients.

Gala-SR

Gala-SR Chemical Structure

CAS No. : 3092129-97-7

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All ROR Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Gala-SR (Gala-SR1078) is an RORα agonist. Gala-SR ameliorates rhythm disorders by enhancing the amplitude of the circadian rhythm. Gala-SR can be used for the study of periodontitis[1].

IC50 & Target

RORα

 

In Vitro

Gala-SR (1-100 μM, 24-72 h) significantly improved Human U2OS cell compatibility through galactose modification[1].
Gala-SR (5 μM, 24 h) significantly upregulates the mRNA expression of G6Pase and FGF21, direct target genes of RORα/γ, in HepG2 cells[1].
Gala-SR (5 μM) selectively enhances RORα transcriptional activation activity in HEK293T cells[1].
Gala-SR (5 μM, 24 h) shows significantly reduced activation effects on the G6Pase and FGF21 genes after RORα is knocked down[1].
Gala-SR (5 μM) targets and activates RORα primarily through its hydrolyzable galactose modification[1].
Gala-SR (2-5 μM) significantly enhances the bioluminescence levels and rhythmic amplitude of the BMAL1 and Per2 reporter genes in U2OS cells, and enhances the expression of the BMAL1 protein[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Real Time qPCR[1]

Cell Line: HepG2 cells
Concentration: 5 μM
Incubation Time: 24 h
Result: Upregulated the mRNA expression of G6Pase and FGF21, direct target genes of RORα/γ, in HepG2 cells.
Parmacokinetics
Species Dose Route T1/2 Tmax Cmax AUC MRTINF_obs
Mice[1] 10 mg/kg i.p. 3.43 h 0.5 h 1313.1 ng/mL 6077.31 ng·h/mL 4.5 h
Mice[1] 10 mg/kg i.v. 2.49 h 0.5 h 4992.46 ng/mL 8176.18 ng·h/mL 2.97 h
In Vivo

Gala-SR (10 mg/kg, 1 h before light off, i.p., once daily for 2 weeks) significantly enhances the amplitude of activity rhythm and total activity in mice[1].
Gala-SR (10 mg/kg, lights on, once) enhances liver luciferase signaling in PER2::LUC knock-in mice, indicating enhanced BMAL1 expression[1].
Gala-SR (10 mg/kg, i.p., once daily for 3 weeks) restores the amplitude of periodontal tissue rhythm in periodontal mice with periodontitis, inhibits the NF-κB inflammatory pathway, and alleviates periodontitis-related bone loss[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6J mice were first acclimatized to a 12-hour light/12-hour dark (L:D) condition for 2 weeks, and then switched to continuous darkness (D:D) to induce circadian rhythm disorder[1].
Dosage: 10 mg/kg
Administration: 1 hour before the end of the light exposure, i.p., once daily for 2 weeks
Result: Significantly enhanced the amplitude of the activity rhythm and the total activity level in mice.
Animal Model: PER2::LUC gene knock-in mice[1].
Dosage: 10 mg/kg
Administration: I.p., once, light start time
Result: Enhanced liver luciferase signaling indicates increased BMAL1 expression.
Animal Model: Male C57BL/6 mice, 2 months old, were housed under disrupted conditions for 4 weeks, and a ligature was placed around the cervix of the maxillary second molar to establish the murine periodontitis model[1].
Dosage: 10 mg/kg
Administration: I.p., once daily for 3 weeks
Result: Significantly reduced alveolar bone resorption (increased bone volume/total volume, reduced bone resorption height).
Reduced inflammatory cell infiltration and osteoclast activity.
Downregulated pro-inflammatory factors (TNF-α, IL-6) and upregulates anti-inflammatory factors (IL-10).
Molecular Weight

623.42

Formula

C24H22F9NO8

CAS No.
SMILES

OC[C@H]1O[C@@H](OCOC(C(F)(F)F)(C(F)(F)F)C2=CC=C(NC(C3=CC=C(C(F)(F)F)C=C3)=O)C=C2)[C@H](O)[C@@H](O)[C@H]1O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Gala-SR
Cat. No.:
HY-179514
Quantity:
MCE Japan Authorized Agent: